Thus, we asked the question of whether the treatment of CLL’s PBMC cultures with TNF could induce a modification of the NLC phenotype, leading in turn to a decrease in CLL cells viability. The gene discussed is TNF; the disease is B-cell chronic lymphocytic leukemia.